Scienture Holdings, Inc. (SCNX) Stock

NASDAQ: SCNXHealthcare company in the pharmaceutical retailers industry, based in Commack, NY.

Scienture stock price chart

SCNX interactive chart →

SCNX stock quote & key statistics

Scienture earnings per share

Income →

Earnings per share

Scienture revenue & net income

Income →

RevenueNet income

Scienture annual financials

Income statement →

Scienture Holdings, Inc. revenue, net income and EPS by fiscal year
Fiscal year	Revenue	Net income	EPS
FY2025	$431,609	-$41.5M	-$1.13
FY2024	$136,643	$9.1M	$17.06
FY2023	$1.4M	-$17.8M	-$20.49
FY2022	$10.3M	-$3.5M	-$6.15
FY2021	$9.9M	-$5.3M	-$9.90

Fiscal year ending December 31. Source: company filings via EODHD.

About Scienture Holdings, Inc.

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen.

It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.

Scienture stock FAQ

What is the Scienture stock ticker symbol?

Scienture Holdings, Inc. trades on the NASDAQ under the ticker symbol SCNX.

What sector and industry is Scienture in?

Scienture Holdings, Inc. is classified in the Healthcare sector, Pharmaceutical Retailers industry.

How many employees does Scienture have?

Scienture Holdings, Inc. has about 4 full-time employees.

What were Scienture's revenue and earnings last fiscal year?

Scienture reported revenue of $431,609 and net income of -$41.5M in fiscal 2025, with earnings per share of -$1.13. Revenue grew 215.9% from the prior year.

When did Scienture go public?

Scienture stock began trading on April 27, 2010.